Trending Articles

article thumbnail

Opinion: RFK Jr. says medical journals are ‘corrupt.’ As former NEJM editors, we know he’s wrong

STAT

American medical research is a unique source of national pride and reputation — some would say the United States’ most important export. Yet Secretary of Health and Human Services Robert F. Kennedy Jr. seems bent on destroying our greatest successes. As the latest strike, Kennedy is going after the publications that disseminate medical research.

363
363
article thumbnail

A biopharma doubles down on diversity goals through a newly created position

PharmaVoice

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

UCB reports success in phase 3 study of fenfluramine for CDD

Pharma Times

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs UCB reports success in phase 3 study of fenfluramine for CDD by John Pinching | 30th Jun 2025 | News Positive trial results offer hope for those with ultra-rare epileptic disorder UCB has announced that its phase 3 trial evaluating fenfluramine in CDKL5 deficiency disorder (CDD) achieved its primary and

Diabetes 129
article thumbnail

Feds unveil largest healthcare fraud takedown: $14.6B in alleged schemes, 324 charged

Beckers Hospital Review

The Justice Department, through its 2025 National Health Care Fraud Takedown investigation, has charged 324 defendants in schemes involving more than $14.6 billion in intended losses to Medicare, Medicaid and other government programs. Five things to know: 1. The 2025 operation was the largest in the department’s history, more than double the previous record of $6 billion, according to a June 30 department news release. 2.

Hospitals 116
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Embrace deprescribing and stay curious in complex cases, pharmacists told

The Pharmacist

Practice pharmacists should build deprescribing into routine care, an exclusive event has heard, with delegates encouraged to stay curious, listen to patients and ask the right questions when faced with complex prescribing decisions. Lelly Oboh, consultant pharmacist for older people at Guy’s and St Thomas’ NHS Trust and overprescribing lead for South East London ICB, […] The post Embrace deprescribing and stay curious in complex cases, pharmacists told appeared first on The Pharmacist.

96

More Trending

article thumbnail

AI’s ‘massive transition’ in biopharma shapes leadership mindsets — tension and all

PharmaVoice

The AI revolution is driving tension between new technology and the traditional approaches in drugmaking. Biopharma leaders are trying to navigate those turbulent waters.

173
173
article thumbnail

Generic drugmaker Hikma pledges $1bn in US investment

pharmaphorum

With tariffs looming, Indian drugmaker Hikma has said it will spend $1bn to expand its manufacturing and R&D operations in the US by 2030.

98
article thumbnail

Regeneron bispecific approved for myeloma; Concentra to buy IGM

BioPharma Dive

Lynozyflic is one of two bispecific antibodies Regeneron hopes will lift its oncology business. Meanwhile, IGM is the latest struggling biotech to agree to a buyout deal from Concentra.

99
article thumbnail

Pharmacies’ clinical services offering to expand under NHS 10-year plan

The Pharmacist

The government has pledged to ‘transition’ community pharmacy from a dispensing-focused service to offering more clinical services, as part of its long-awaited NHS 10-year plan. Published today, the 168-page blueprint has committed to increasing the role of community pharmacy in the management of long-term conditions, including treatment of obesity, high blood pressure and high cholesterol. […] The post Pharmacies’ clinical services offering to expand under NHS 10-year plan appeared first

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: HHS to continue funding cancer prevention, tracking work in states after uncertainty

STAT

WASHINGTON — The Department of Health and Human Services will renew funding to states for cancer prevention and tracking efforts, alleviating anxieties among local officials about the future of their work.  Over 50 notices had gone out as of Monday, an HHS spokesperson said. The rest of the awards will be sent to states, tribes, and other contractors “no later than early next week,” press secretary Emily Hilliard told STAT in an email.

264
264
article thumbnail

Drugmakers Notch a $5 Billion Win in Republicans’ Policy Bill

NY Times

More medicines will be spared from Medicare price negotiations, a change that is projected to wipe out billions in savings for the federal government.

89
article thumbnail

FDA loosens restrictions on first-gen CAR-T therapies

pharmaphorum

There is enough experience with the first wave of autologous CAR-T therapies to allow strict rules ensuring their safe use to be relaxed, says FDA.

95
article thumbnail

Biocon Biologics expands insulin access in Malaysia

Express Pharma

Biocon Biologics (BBL), a global biosimilars company, announced that its Malaysian subsidiary, Biocon Sdn. Bhd., has supplied over 100 million cartridges of recombinant human insulin (rh-insulin) to Malaysia’s Ministry of Health (MoH). This milestone marks a key development in BBL’s support for diabetes care and insulin accessibility in Malaysia. Since its entry into the Malaysian market in 2016, Biocon Biologics has supported more than 345,000 diabetes patients through the supply of rh-insulin.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

BREAKING: Pharmacists to staff new neighbourhood health centres

The Pharmacist

Pharmacists will staff the government’s new neighbourhood health centres alongside nurses, doctors, social care workers and others, the Prime Minister has announced. Sir Keir Starmer has this evening set out early details of the highly anticipated 10-year plan for the NHS ahead of its publication in the morning – largely focusing on the government’s ambitions […] The post BREAKING: Pharmacists to staff new neighbourhood health centres appeared first on The Pharmacist.

76
article thumbnail

Why this activist is putting her body on the line for Americans with disabilities

STAT

Flanked by her friends as lawmakers debated the future of a 60-year-old health care plan, Latoya Maddox raised her voice, shouting, “No cuts to Medicaid! No cuts to Medicaid!” The chanting, during a meeting of the House Energy and Commerce Committee on May 13, quickly earned her and her fellow disabled activists in the room a rough escort out by Capitol Police.

237
237
article thumbnail

NHS manager ordered to stop selling ‘sleep drug-laced’ children’s gummies

The Guardian - Pharmaceutical Industry

Regulator tells Sally Westcott to pull product that allegedly has undeclared levels of prescription-only melatonin An NHS manager has been stopped from selling children’s gummies allegedly laced with undeclared levels of a prescription-only sleeping drug, the Guardian can reveal. Magnesium glycinate gummies for children who have trouble sleeping have been sold since March last year by Nutrition Ignition, an Epsom-based company owned by Sally Westcott, whose other job is a clinical therapy lead a

86
article thumbnail

Neopharmed buys Euro rights to BioCryst's HAE drug Orladeyo

pharmaphorum

Neopharmed Gentili buys BioCryst's hereditary angioedema drug Orladeyo in Europe, the first stage of an international expansion for the Italian firm.

98
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Lupin launches Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03 per cent and 0.06 per cent in the US

Express Pharma

Lupin announced the launch of Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03 per cent and 0.06 per cent, in the United States. Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03 per cent and 0.06 per cent are bioequivalent to Atrovent Nasal Spray, 0.03 per cent and 0.06 per cent, of Boehringer Ingelheim Pharmaceuticals. Ipratropium Bromide Nasal Solution (Nasal Spray) 0.03 per cent is indicated for the symptomatic relief of rhinorrhea associated with allergic and nonallergic perennia

82
article thumbnail

The best and worst states for healthcare — and why it’s complicated

Beckers Hospital Review

A new national analysis offers a nuanced view of how healthcare access, affordability, treatment quality and hospital use intersect across the United States. The “ 2025 Scorecard on State Health System Performance ” from Commonwealth Fund evaluates all 50 states and the District of Columbia using 50 indicators spanning healthcare access and affordability, prevention and treatment, avoidable hospital use and costs, health outcomes, healthy behaviors, and equity.

Hospitals 106
article thumbnail

STAT+: AbbVie snaps up CAR-T company in a deal worth $2.1 billion

STAT

AbbVie said Monday that it would pay up to $2.1 billion to acquire Capstan Therapeutics , a startup developing CAR-T therapies for autoimmune conditions, fibrosis, and cancer.  AbbVie will pay up to $2.1 billion in cash when the deal closes, according to a press release. The companies did not give further details about the financial terms or a timeline for completing the acquisition.

225
225
article thumbnail

Moderna flu vaccine shows superior results in phase 3 study

Pharma Times

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Moderna flu vaccine shows superior results in phase 3 study by John Pinching | 1st Jul 2025 | News Data shows mRNA-1010 could better protect adults aged 50 and above Moderna has reported positive phase 3 results for its seasonal flu vaccine, mRNA-1010, which outperformed a standard-dose licensed influenza vac

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

New medicine access times to be slashed under NHS plan

pharmaphorum

Reports suggest a new framework for medicine reviews and a push to reduce NHS reliance on overseas-trained staff will feature in the 10-year plan.

97
article thumbnail

Cadila Pharmaceuticals launches Bilacad Dex Syrup

Express Pharma

Cadila Pharmaceuticals has announced the launch of Bilacad Dex Syrup, to address the increasing burden of respiratory and allergy-related conditions with a novel fixed-dose combination of Bilastine, Dextromethorphan, and Phenylephrine. Bilacad Dex Syrup is a triple-action formula for comprehensive respiratory relief. It targets multiple symptoms associated with the common cold and allergic rhinitis, including cough, nasal congestion, and allergic manifestations such as sneezing and itching.

Dosage 79
article thumbnail

Cybersecurity takes back seat at rural hospitals facing Medicaid cuts: Report

Beckers Hospital Review

A growing number of small and rural hospitals are delaying cybersecurity improvements due to looming Medicaid funding cuts, according to a June 30 report from Black Book Research. The survey of 187 leaders at hospitals with fewer than 150 beds found that 25% of U.S. hospitals are vulnerable to cyberattacks because of staffing shortages, outdated technology and low cybersecurity budgets.

article thumbnail

STAT+: New blood test could predict preeclampsia in the first trimester

STAT

A new blood test could predict preeclampsia as early as the first trimester. In a new study, researchers successfully predicted the early-onset subtype of the prenatal condition up to five months before clinical diagnosis. The findings are being presented Monday during the annual meeting of the European Society of Human Reproduction and Embryology, in Paris.

189
189
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.